Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CV Sciences (CVSI) EBT Margin (2016 - 2025)

CV Sciences' EBT Margin history spans 13 years, with the latest figure at 11.73% for Q3 2025.

  • For Q3 2025, EBT Margin rose 7.0% year-over-year to 11.73%; the TTM value through Sep 2025 reached 10.34%, up 592.0%, while the annual FY2024 figure was 15.29%, 3464.0% down from the prior year.
  • EBT Margin for Q3 2025 was 11.73% at CV Sciences, down from 7.21% in the prior quarter.
  • Across five years, EBT Margin topped out at 137.56% in Q1 2023 and bottomed at 180.22% in Q4 2021.
  • The 5-year median for EBT Margin is 19.05% (2024), against an average of 26.55%.
  • The largest annual shift saw EBT Margin soared 17163bps in 2023 before it plummeted -15310bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 180.22% in 2021, then soared by 66bps to 61.05% in 2022, then soared by 62bps to 23.1% in 2023, then increased by 18bps to 19.05% in 2024, then soared by 38bps to 11.73% in 2025.
  • Per Business Quant, the three most recent readings for CVSI's EBT Margin are 11.73% (Q3 2025), 7.21% (Q2 2025), and 2.83% (Q1 2025).